Article Details

AstraZeneca In-Licenses New Suite Of COVID-19 Antibody Candidate(s) - Benzinga

Retrieved on: 2022-05-17 20:09:21

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca In-Licenses New Suite Of COVID-19 Antibody Candidate(s) - Benzinga. View article details on HISWAI: https://www.benzinga.com/general/biotech/22/05/27259695/astrazeneca-in-licenses-new-suite-of-covid-19-antibody-candidate-s

Excerpt

AstraZeneca plc · In addition to the initial sum, AstraZeneca will pay possible royalty payments as part of the exclusive license to develop pre- ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up